Come visit APDM at the upcoming IARC conference in our nation’s capital, Washington D.C. APDM will have a booth to demonstrate our technology, and APDM’s General Manager, Matthew Johnson, will be presenting two posters, one with Takeda Pharmaceutical about Friedreich’s Ataxia (FA) and another with Biogen and Pfizer about their collaborative study for creating novel functional biomarkers in both FA and SCA populations.

The International Ataxia Research Conference will be a comprehensive scientific review of new research into ataxias, covering topics from the molecular basis of disease to potential therapeutic treatments and clinical trials. The conference will include Friedreich’s ataxia and other recessive ataxias (e.g. ataxia with oculomotor apraxia), dominant ataxias (e.g. spinocerebellar ataxias, DRPLA, episodic ataxias) and autoimmune ataxias. The meeting is aimed at academic, clinical and industry researchers with an interest in ataxia research and drug development